Event – The Access to Medicine Crisis: Innovation in the Pharmaceutical Industry

Date: 15/06/2015, 20:00 Location: Hardewikerstraat 7

On the 15th of June, SIB and IFMSA will organize an evening on the access to medicine crisis in developing countries and the ways the pharmaceutical industry is changing to cope with this problem. Tonight we’ll have guests who will speak about two different initiatives to improve access to medicine for developing countries, namely the Drugs for Neglected Diseases initiative (DNDi) and the Access to Medicine-Index (A2M-index).

For more information, please refer to here

Third event GHLG: Health and human rights on the ground

Dear all,

We kindly invite you to the third event of Global Health Law Groningen initiative on Friday 29th May from 15.00 – 17.00, on Van Swinderen Huys, Oude Boteringestraat, Club Lounge. This time we focus on the implementation of the right to health in practice. Please feel free to register in advance with Ms. Esther Knot (email stair@rug.nl).

How do you actually apply the right to health on the ground? The Danish Institute for Human Rights is developing the AAAQ Toolbox – an innovative assessment tool that offers practical guidance for state, business and civil society actors.

Senior advisor Mads Holst Jensen PhD and researcher Lena Kähler MSc will share their experiences working with a variety of actors including pharmaceutical companies to translate the right to health from principles into action on the ground.

15:00 – 16:30 Programme with DHRI speakers: Mads Holst Jensen PhD & Lena Kähler MSc

  • The AAAQ toolbox (abstract also available at https://ghlgblog.wordpress.com)
  • A tool to assess essential medicines and reproductive health
  • Working with human rights on the ground
  • Open Q&A

16:30 – 17:00 Reception kindly provided by PIPR

Click the following flyer for details:

Third Event-Health&HumanRightsOnTheGround

The Ebola crisis: challenges for Global Health Law

Dr. Brigit Toebes, University of Groningen

The recent Ebola crisis has caused approximately 11.000 deaths so far. Compared to other global health crises, including the deaths caused by armed conflicts and chronic diseases, this is still a small amount. Yet, from a global and domestic health law and governance perspective, this crisis raises a number of vital questions and challenges, which were also addressed during a recent SHARES debate organised by the University of Amsterdam. It reveals a lack of good governance and leadership at both domestic and international levels. It challenges us to ask the questions: what went wrong, who is responsible, and for what? This contribution to our new blog ‘Global Health Law Groningen’ looks at these questions from the perspective of international or global health law.

Continue reading